Trial Profile
Efficacy and safety of perampanel in adults with pharmacoresistant epilepsy at a large UK tertiary epilepsy center
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 10 Apr 2018 New trial record